Authors: | Bornemann, L. D.; Spiegel, H. E.; Dziewanowska, Z. E.; Krown, S. E.; Colburn, W. A. |
Article Title: | Intravenous and intramuscular pharmacokinetics of recombinant leukocyte A interferon |
Abstract: | Interferon is currently being evaluated for the treatment of disseminated cancer and viral diseases. Alpha interferons have shown to be effective in the treatment of a number of malignancies. Recombinant leukocyte A interferon (rIFN-αA) is an alpha interferon produced by recombinant DNA techniques. A kinetic evaluation of rIFN-αA following intravenous and intramuscular administration has not been adequately defined. The present study was designed to evaluate the kinetics of rIFN-αA following intravenous and intramuscular administration of 3, 9 or 18×106 units to patients with disseminated cancer. A preliminary report of this study was presented at the meeting of the American Society for Clinical Pharmacology and Therapeutics in San Diego, March 1983 (1). © 1985 Springer-Verlag. |
Keywords: | adult; clinical article; aged; middle aged; interferon; alpha interferon; antineoplastic agent; cancer immunotherapy; kinetics; antivirus agent; virus infection; drug blood level; drug therapy; therapy; intravenous drug administration; pharmacokinetics; intramuscular drug administration; injections, intramuscular; interferon type i; cancer patients; dna, recombinant; cancer; humans; human; male; female; priority journal; recombinant alpha interferon a; i.v.-/i.m. administration; recombinant leukocyte a interferon; rifn-αa |
Journal Title: | European Journal of Clinical Pharmacology |
Volume: | 28 |
Issue: | 4 |
ISSN: | 0031-6970 |
Publisher: | Springer Verlag |
Date Published: | 1985-07-01 |
Start Page: | 469 |
End Page: | 471 |
Language: | English |
DOI: | 10.1007/bf00544369 |
PUBMED: | 4029251 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | Article -- Export Date: 26 October 2021 -- Source: Scopus |